T O P I C A L S

Look to Paddock for All of Your Compounding Needs I N J E C T A B L E S

O R A L L I Q U I D S

O R A L S O L I D S

S U P P O S I T O R I E S

C O M P O U N D I N G

ORA-BLEND SF

Flavored Sugar-Free Oral

Suspending Vehicle
ORA-BLEND SF

Paddock ORA-BLEND SF
Size NDC

473 ML (One Pint) 0574-0312-16

Ora-Blend SF is a flavored sugar-free oral suspending vehicle used to simplify the

process involved in the extemporaneous compounding of oral suspensions.
Medicated powder can be incorporated into Ora-Blend SF to form elegant, uniform
and physically stable suspensions.

Applications Ingredients

Ora-Blend SF combines the suspending properties of Ora-Plus Purified water, sorbitol, glycerin, flavoring, microcrystalline

with the flavoring agents of Ora-Sweet SF and is ideal for: cellulose, carboxymethylcellulose sodium, xanthan gum, car-
rageenan, calcium sulfate, trisodium phosphate and sodium
Pediatric suspensions
saccharin, sodium phosphate, citric acid and sodium citrate
Geriatric suspensions as buffers, dimethicone antifoam emulsion. Preserved with
methylparaben, propylparaben and potassium sorbate.

Properties Specifications
Ora-Blend SF is an aqueous-based, sweetened vehicle consist- Appearance: Opaque, pinkish liquid with a pH of
ing of a synergistic blend of suspending agents that have a approximately 4.2
high degree of colloidal activity. The suspending agents form a Taste: Sweet citrus-berry flavor
structured, gel-like matrix which suspend particles and allow for
little settling. Ora-Blend SF is buffered to a slightly acidic pH to Viscosity: Approximately 1000 cps at 25C via Brookfield
help reduce degradation of medicinal agents through oxidation. viscometer
An anti-foam agent is incorporated into Ora-Blend SF to allow Osmolality: 1073 mOsm/Kg
for vigorous shaking with minimal foam.
Order through your wholesaler. For additional information please contact
Paddock Laboratories at 1-800-328-5113 or www.paddocklabs.com

2010 PADDOCK LABORATORIES, LLC

0312-02-0310 Now part of the Perrigo Family
 ORA-BLEND SF Formulating and Compounding Examples
SPIRONOLACTONE 5 mg/mL, plus
LAMOTRIGINE 1 mg/mL1, 100 mL HYDROCHLOROTHIAZIDE 5 mg/mL3,120 mL
Lamotrigine 100 mg/tablet 1 tablet Spironolactone-Hydrochlorothiazide
Ora-Blend SF q.s. 100 mL 25 mg/25 mg/tablet 24 tablets
Expiration 91 days at 4C and 25C Ora-Blend SF q.s. 120 mL
Protect from light Expiration 60 days at 5C and 25C
Shake well before using Protect from light
Shake well before using

VERAPAMIL HYDROCHLORIDE
RIFAMPIN 25 mg/mL2, 120 mL 50 mg/mL3, 120 mL
Rifampin 300 mg/capsules 10 capsules Verapamil HCI 80 mg/tablet 75 tablets
Ora-Blend SF q.s. 120 mL Ora-Blend SF q.s. 120 mL
Expiration 28 days at 5C and 25C Expiration 60 days at 5C and 25C
Protect from light Protect from light
Shake well before using Shake well before using

General Directions For Compounding ORA-BLEND SF Suspensions

Calculate the total amount of active ingredient and volume of solution needed to 1
American Journal of Health-System Pharmacists 1999;56:240-2.
create a suspension of the proper concentration. (Calculations are provided in the 2
American Journal of Health-System Pharmacists 1998;55:1804-9.
examples above.) It may be wise to add approximately 10% overage for compounding 3
American Journal of Health-System Pharmacists 1996;53:2179-84.
losses.

Crush tablets with a mortar and pestle to a fine powder. If the compound is already
in the powder form, use the mortar and pestle to smooth out the powder.
Add a small amount of Ora-Blend SF and triturate to a thick, smooth paste. Add
the remainder of Ora-Blend SF by geometric dilution.
Mix briefly with a mortar and pestle until a uniform suspension is formed.
Dispense in a tight, light resistant amber bottle with appropriate labeling.
Label with an expiration date. If the stability of the medication in an oral suspen-
sion or syrup is unknown, conservative dating is suggested.
Contraindications
Ora-Blend SF is contraindicated in persons who have shown hypersensitivity to any of the listed
ingredients.
All information presented is intended to demonstrate the application of Paddock vehicles for com-
pounding. Paddock products are sold on the understanding that purchasers will make their own
determinations as to the suitability, safety and effectiveness of their applications. The uses present-
ed by Paddock are only to assist our customers in exploring possible applications. All information
and data presented are believed to be accurate and reliable, but are presented without the assump-
tion of any liability by Paddock Laboratories. Paddock Laboratories does not warrant against
infringements of patents of third parties by reason of any uses made of the vehicles in combination
with other material or in the operation of any process, and purchasers assume all risks of patent
infringement by reason of any such use, combination or operation.

Depending on the medicinal agent used, label containers "Shake Well Before
Using," "Protect From Light," and "Keep Refrigerated."

Now part of the Perrigo Family